PDx RL is a life science firm focused on democratizing multi-omics to discover new healthcare solutions. We support research in academia and biopharma, while also providing services and nurturing innovations in public health.
What We Deliver
Clinical Diagnostics: Transforming Diagnostics, Improving Patient Care.
Our goal is to advance diagnostics and therapeutic practices through precision and AI-driven decision-support insights, empowering practitioners with the tools they need for precision medicine and therapeutic applications.

Sequencing-as-a-Service – delivering reliable, accurate, and actionable sequencing results.
We provide a wide range of sequencing services to support researchers, clinicians, and pharmaceutical companies in scientific discovery, medical innovation, clinical diagnostics, and precision medicine.
NGS Analytics – driving innovation and precision healthcare
Unlocking the full potential of Next-Generation Sequencing (NGS) data with comprehensive suite of NGS analytics solutions.

Drug Discovery
We offer drug discovery services to accelerate the development of novel therapeutics. Our integrated platform uses advanced technologies and expertise to drive innovation and deliver impactful solutions.
Target Identification & Discovery
In drug discovery, we use bioinformatics analysis to identify potential therapeutic targets by scrutinizing genomic, proteomic, and transcriptomic data. Omics-based methodologies uncover disease-associated pathways and biomarkers, laying the groundwork for target discovery.


Animal Research & Preclinical Trial
We conduct ethical and rigorous animal research to advance biomedical discoveries. Our services include customizing animal models, designing preclinical studies, and ensuring optimal animal welfare. We also offer in vivo pharmacology assessments, toxicology studies, disease modeling, biomarker discovery, advanced imaging, molecular analysis, xenograft studies, data management, and regulatory compliance. Partner with us to drive scientific innovation and improve human health outcomes.
CRISPR-Cas9-Based Genome Editing Services
Our CRISPR-Cas9-Based Genome Editing Services offer precise genetic manipulation solutions for research. We provide knockouts, knock-ins, and endogenous reporter tagging capabilities for targeted gene modifications. Customized strategies, validation protocols, and expert consultation ensure accuracy and efficiency. We offer various delivery methods and prioritize off-target analysis and ethical considerations. Partner with us to unlock the potential of CRISPR-Cas9 technology in precision genome editing.
Partner with us to unlock the potential of CRISPR-Cas9 technology in precision genome editing. Know More